Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia 4Leukemia, Myeloid, Acute 3Neutropenia 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Recurrence 1Myelodysplastic Syndromes 1Leukemia, Promyelocytic, Acute 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Methotrexate 11Busulfan 11Cytarabine 10fludarabine 8Daunorubicin 8Cyclophosphamide 8fludarabine phosphate 7Whole-Body Irradiation 7Etoposide 7Tacrolimus 6Mitoxantrone 5Melphalan 5Idarubicin 5Thioguanine 4Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Azacitidine 4thymoglobulin 3Radiotherapy 3Filgrastim 3Early Intervention, Educational 3Decitabine 3Cyclosporine 3Asparaginase 3Antilymphocyte Serum 3merphos 2luspatercept 2decitabine and cedazuridine drug combination 2Tretinoin 2Stem Cell Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Myelodysplastic Syndromes × Amsacrine × Clear all
NCT00003436 2013-12-04

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 3 Completed
2,000 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡